Prosecution Insights
Prosecution Insights
6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (17%) |
| §102 only | 1 (17%) |
| §112 only | 3 (50%) |
| Double-patenting + other | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KONOPKA, CATHERINE ANNE | 1 | 58.2% | +64.5% |
| MEAH, MOHAMMAD Y | 1 | 70.9% | +42.6% |
| SAEED, KAMAL A | 1 | 83.8% | +9.6% |
| HAVLIN, ROBERT H | 1 | 51.6% | +27.9% |
| WILLIS, DOUGLAS M | 1 | 82.4% | +19.5% |
| VAJDA, KRISTIN ANN | 1 | 84.0% | +10.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18450775 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | SAEED, KAMAL A | — |
| 18260549 | METHODS AND COMPOUNDS FOR TREATING FRIEDREICH'S ATAXIA | WILLIS, DOUGLAS M | — |
| 18256864 | METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPY 1 | VAJDA, KRISTIN ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17759944 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | HAVLIN, ROBERT H | 71d |
| 18600510 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | KONOPKA, CATHERINE ANNE | — |
| 18590521 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | MEAH, MOHAMMAD Y | — |
| 18260549 | METHODS AND COMPOUNDS FOR TREATING FRIEDREICH'S ATAXIA | WILLIS, DOUGLAS M | — |
| 18256864 | METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPY 1 | VAJDA, KRISTIN ANN | — |
| Art Unit | Apps |
|---|---|
| 1626 | 2 |
| 1652 | 1 |
| 1624 | 1 |
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18600510 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | KONOPKA, CATHERINE ANNE | — | §102§103§112DPOther | Non-Final OA | — | Pending | Mar 08, 2024 |
| 18590521 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | MEAH, MOHAMMAD Y | 1652 | §112 | Non-Final OA | — | Pending | Feb 28, 2024 |
| 18450775 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | SAEED, KAMAL A | 1626 | §103 | Non-Final OA | — | Pending | Aug 16, 2023 |
| 17759944 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | HAVLIN, ROBERT H | 1626 | §102 | Non-Final OA | 71d | Pending | Aug 10, 2023 |
| 18260549 | METHODS AND COMPOUNDS FOR TREATING FRIEDREICH'S ATAXIA | WILLIS, DOUGLAS M | 1624 | §112 | Non-Final OA | — | Pending | Jul 06, 2023 |
| 18256864 | METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPY 1 | VAJDA, KRISTIN ANN | 1622 | §112 | Non-Final OA | — | Pending | Jun 09, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial